Day 1  Tuesday, May 6

7:30-8:20         Mentoring Breakfast-Event Hall
Academic Careers

8:00-8:30         Registration

8:30-8:35        Welcome
Suzanne Tomlinson-Mathis, Gulf Coast Consortia

8:35-9:10         Keynote Presentation: Statistical Significance for Causal Inference: How Decision Makers Hijacked Science
Miguel Hernan, Harvard University

Session 1        Preclinical to Clinical: Observed Translational Differences
Moderator       Scott Gilbertson, University of Houston

9:10-9:30        When Humans Do Not Behave Like Lab Animals
Jeff Larson, Tvardi Therapeutics

9:30-9:50        7HP935, a Novel Integrin Agonist for Acceleration of Hematopoietic Stem Cell Engraftment to Reduce the Incidence of Life-Threatening Infections in Allogeneic Stem Cell Transplant Patients
Siddhartha De, 7Hills Pharma

9:50-10:30       Panel Discussion

10:30-11:00    Vendor Session and Networking Break

Session 2        Real World Evidence to Inform Preclinical Development
Moderator       Mohanad Albayyaa, University of Texas Medical Branch at Galveston

11:00-11:20    Clinical Trials and Registries: Driving Scientific Innovation and Medical Breakthroughs
Wissam Khalife, University of Texas Medical Branch at Galveston

11:20-11:40    Talk title TBA
Long Doan, SpyGlass Pharma Inc.

11:40-12:15    Panel Q&A and Discussion

12:15 – 12:30   Rapid Fires Presentation, even-numbered posters

Moderator       TBA

12:10-12:15    TBA
12:15-12:20    TBA
12:20-12:25    TBA
12:25-12:30    TBA

12:30-2:30       Lunch and even-numbered posters – Event Hall

12:30-1:30       Lunch
1:30-2:30         Poster presentations, even-numbered posters

Session 3        Vendor Presentations – Auditorium

2:30-2:40         TBA
2:40-2:50         TBA
2:50-3:00         TBA

Session 4        Innovative Methods for Identifying New Targets
Moderator       Scott Gilbertson, University of Houston

3:00-3:20         Talk title TBA
Deepak Nijhawan, University of Texas Southwestern

3:20-3:40         Discovery of Novel First-in-Class Medicines with a Suite of AI-Enabled Platform Technologies
Aimee Iberg, Recursion Pharmaceuticals

3:40-4:20         Panel Q&A and Discussion

Session 5        Houston-Based Resources for Healthcare Innovation
Moderator       Suzanne Tomlinson-Mathis, Gulf Coast Consortia

4:20-4:25         Jennifer Roohi, TMC Innovation
4:25-4:30         Lacey Tezino, GCC REACH
4:30-4:35         Colby Squire, K2Bio
4:35-4:40         Allison Rhines, Jlabs
4:40-4:45         Monique Knighten, Portal Innovation
4:45-4:50         Will Tankersley, Levit Green
4:50-4:55         Jeffrey Wade, BioHouston

5:00        Reception and Poster Viewing-Event Hall

Day 2  Wednesday, May 7

8:00-8:50         Mentoring Breakfast-Event Hall (Industry Careers)

8:30-9:00         Registration

9:00-9:35         Keynote Presentation 3: Talk title TBA
Michelle Arkin, University of California San Francisco

Session 6        New Therapeutic Strategies
Moderator       Reid Powell, Texas A&M Institute of Bioscience and Technology

9:35-9:55        New Strategies for Small Molecule Development
Stanton McHardy, UT San Antonio

9:55-10:20     New Strategies for Antibody Drug Modalities
Chen-Ni Chin, IGM Biosciences, Inc.

10:20-11:00    Panel Discussion

11:00-11:30     Vendor Session and Networking Break

Session 7        GCC IDDD Core Network Showcase
Moderator       Suzanne Tomlinson Mathis, Gulf Coast Consortia

11:30-11:40    GCC IDDD Core Network
Suzanne Tomlinson-Mathis, Gulf Coast Consortia

11:40-11:50    GCC Drug Discovery Resource Center
Cliff Stephan, Texas A&M Institute of Bioscience and Technology

11:50-11:55    GCC Center for Comprehensive PK/PD and Formulation
Dong Liang, Texas Southern University

11:55-12:00    Center for Innovative Drug Discovery
Stanton McHardy, University of Texas San Antonio

12:00-12:05    Advanced Protein Therapeutics
Jennifer Maynard, University of Texas

12:05-12:10    Advanced Cancer Antibody Drug Modalities Core
Zhiqiang An, UTHealth

12:10-12:20    Preclinical Development Cor for Large Molecules
Qingyun “Jim” Liu, UTHealth

12:20-12:25    Accelerator for Cancer Therapeutics
Supriya Sinha, TMC Innovation

12:25-12:30    Targeted Therapeutics Drug Discovery and Development
Kevin Dalby, University of Texas

Rapid Fire presentation, odd-numbered posters
Moderator       TBA

12:30-12:35    TBA
12:35-12:40    TBA
12:40-12:45    TBA

12:45-2:30       Lunch and odd-numbered posters – Event Hall

12:45-1:30       Lunch
1:30-2:30          Poster presentations, odd-numbered posters

Session 8:          Medical Devices
Moderator       Jiaxin Feng, Texas A&M University

2:30-2:50         TBA

2:50-3:10        TBA

3:10-4:00         Panel Q&A and Discussion

4:00                 Closing Remarks